Patrick Wagner

Title: Patrick Wagner: Innovator in PDE2 Inhibitors

Introduction

Patrick Wagner is a notable inventor based in Brumath, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific neurological conditions. His work focuses on innovative therapeutic methods that can improve patient outcomes.

Latest Patents

Patrick Wagner holds a patent for "Benzo-1,4-diazepin-2-one derivatives as phosphodiesterase PDE2 inhibitors, preparation and therapeutic use thereof." This invention relates to compounds that exhibit PDE2 inhibitory activities. The patent outlines therapeutic methods for administering these compounds, especially for treating various diseases affecting the central or peripheral nervous system. Additionally, it discusses pharmaceutical compositions that include these compounds and the methods for their preparation. He has 1 patent to his name.

Career Highlights

Wagner is associated with Via Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work is pivotal in the pharmaceutical industry, contributing to the understanding and treatment of neurological disorders.

Collaborations

Throughout his career, Patrick has collaborated with notable colleagues, including Jérôme Duranton and Cesare Mondadori. These partnerships have enhanced his research and broadened the impact of his inventions.

Conclusion

Patrick Wagner's innovative work in the field of PDE2 inhibitors showcases his commitment to advancing medical science. His contributions are vital for developing new therapeutic options for patients with neurological diseases.